FALZARANO, Maria Sofia
 Distribuzione geografica
Continente #
NA - Nord America 6.255
AS - Asia 3.023
EU - Europa 2.817
SA - Sud America 584
AF - Africa 64
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.800
Nazione #
US - Stati Uniti d'America 6.055
SG - Singapore 1.236
CN - Cina 847
PL - Polonia 762
IT - Italia 585
BR - Brasile 507
DE - Germania 414
HK - Hong Kong 269
UA - Ucraina 263
GB - Regno Unito 244
VN - Vietnam 191
TR - Turchia 186
FI - Finlandia 112
CA - Canada 105
RU - Federazione Russa 98
SE - Svezia 93
MX - Messico 71
IN - India 61
FR - Francia 56
ID - Indonesia 53
JP - Giappone 47
AU - Australia 41
BE - Belgio 39
NL - Olanda 38
AR - Argentina 33
ES - Italia 32
ZA - Sudafrica 31
PK - Pakistan 25
BD - Bangladesh 23
CZ - Repubblica Ceca 18
IQ - Iraq 18
LT - Lituania 15
NZ - Nuova Zelanda 13
MA - Marocco 12
VE - Venezuela 11
CL - Cile 10
RO - Romania 9
CO - Colombia 8
CH - Svizzera 7
TH - Thailandia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
EG - Egitto 6
KR - Corea 6
KE - Kenya 5
AZ - Azerbaigian 4
CR - Costa Rica 4
EC - Ecuador 4
EE - Estonia 4
IE - Irlanda 4
IL - Israele 4
LB - Libano 4
NP - Nepal 4
PE - Perù 4
BG - Bulgaria 3
JM - Giamaica 3
KZ - Kazakistan 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
QA - Qatar 3
SA - Arabia Saudita 3
SV - El Salvador 3
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GD - Grenada 2
JO - Giordania 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MK - Macedonia 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PH - Filippine 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KI - Kiribati 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NI - Nicaragua 1
PS - Palestinian Territory 1
Totale 12.794
Città #
Warsaw 759
Singapore 694
Ashburn 684
Fairfield 605
Woodbridge 517
Ann Arbor 360
Houston 358
Chandler 355
Beijing 330
Jacksonville 287
Santa Clara 278
Hong Kong 257
Seattle 231
Wilmington 219
Cambridge 180
Dallas 137
Los Angeles 131
New York 120
Munich 106
Izmir 97
Nanjing 91
Milan 84
Ferrara 80
Princeton 74
Boardman 65
Shanghai 57
San Diego 52
São Paulo 52
Ho Chi Minh City 47
Dong Ket 44
Rome 44
Bremen 43
Brescia 43
Mexico City 43
Brussels 39
Jakarta 38
London 38
Hanoi 35
Montreal 34
Tokyo 32
Addison 31
Turku 31
Buffalo 30
Toronto 30
Hefei 29
Brooklyn 28
Orem 28
Tianjin 28
Chennai 27
Chicago 27
Stockholm 27
Denver 26
Helsinki 25
Johannesburg 25
Phoenix 23
Sydney 23
Poplar 22
Shenyang 22
Nanchang 21
Atlanta 19
Jinan 19
The Dalles 19
Bologna 18
Changsha 18
Boston 17
Hebei 17
Moscow 17
Brno 15
Dearborn 15
Frankfurt am Main 15
Jiaxing 15
Auburn Hills 12
Norwalk 12
Nuremberg 12
Perth 12
Rio de Janeiro 12
Brasília 11
Querétaro 11
Wan Chai 11
Zhengzhou 11
Ankara 10
Charlotte 10
Curitiba 10
Falls Church 10
Florence 10
Hamilton 10
Redwood City 10
Haiphong 9
Mountain View 9
Mumbai 9
Ottawa 9
San Francisco 9
San Jose 9
San Mateo 9
Washington 9
Augusta 8
Columbus 8
Manchester 8
Sakaechō 8
Da Nang 7
Totale 8.732
Nome #
Duchenne muscular dystrophy: From diagnosis to therapy 502
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 426
Meccanismi del danno neuronale indotto dalla tossina mitocondriale sodio azide in colture primarie di corteccia di ratto. Effetti sulle Protein Kinasi C. 424
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 382
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 292
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease 285
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 267
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype 248
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 243
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures 243
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature 238
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 227
Exon skipping-mediated dystrophin reading frame restoration for small mutations 212
Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report 211
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 207
Sodium Azide Induced Neuronal Damage In Vitro: Evidence for Non-Apoptotic Cell Death 204
Antisense modulation of both exonic and intronic splicing motifs induces skipping of a DMD pseudo-exon responsible for X-linked dilated cardiomyopathy 198
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 191
Sodium azide: a useful tool for in vitro studying neurodegenerative diseases. 187
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 183
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 182
Biodistribution and Molecular Studies on Orally Administered Nanoparticle-AON Complexes Encapsulated with Alginate Aiming at Inducing Dystrophin Rescue in mdx Mice 182
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 182
Biodistribution Studies of Polymeric Nanoparticles for Drug Delivery in Mice. 176
Differential activation of protein kinase C isoforms following chemical ischemia in rat cerebral cortex slices 174
Homozygous Recessive Versican Missense Variation Is Associated With Early Teeth Loss in a Pakistani Family 173
null 172
Spatial RNA-mapping reveals the unique patterns of expression and localisation of dystrophin isoforms in the human adult normal brain to improve understanding of brain involvement in muscular dystrophy 169
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH 163
2,3-dihydro-1Himidazo[1,2-b]pyrazole derivatives as potential neutrophils funtions inhibitor 160
Activation of signal tranduction pathway leading to chemotaxis in human neutrophils by a pure chemoattractant. 159
Hydrophilic residues at position 3 highlight unforeseen features of the fMLP receptor pocket 159
Nociceptin/orphanin FQ stimulates human monocyte chemotaxis via NOP receptor activation 156
New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor 155
RNAseq in urine-derived stem cells identified the expression of 308 neuromuscular gene transcripts [NEXT GENERATION SEQUENCING AND EXPERIMENTAL MYOLOGY: P.384] 155
Physical and transcriptional characterization of human urinary stem cell populations 154
Nanoparticle delivery of antisense oligonucleotides and their application in the exon skipping strategy for duchenne muscular dystrophy. 149
Structural characterization of promoter sequences of the gene coding human PKI55 protein, a protein kinase C inhibitor 147
Oligomeric formylpeptide activity on human neutrophils 146
Differential involvement of kinase pathways is required for human neutrophil function triggered by formylpeptides 146
RNA-seq in DMD urinary stem cells recognized muscle-related transcription signatures and addressed the identification of atypical mutations by whole-genome sequencing 145
Nanodiagnostics and nanodelivery applications in genetic alterations 143
P1.19 Whole genetic and protein characterisation in DMD symptomatic female carriers excludes correlation with X-inactivation and transcriptional DMD allele balancing 142
Structure activity relationship of for-Met-Leu-Phe-OMe analogues in human neutrophils 141
FUNCTIONALITY AND DRUG METABOLISM OF FRESHLY AND CRYOPRESERVED CULTURED HUMAN HEPATOCYTES 140
Protective effect of a peptide derived from the endogenous PKC inhibitor PKI55 on the neurosecretory function in ischemic brain slices 139
activation of signal transduction pathway leading to chemotaxis human neutrophils by a pure chemoattractant 135
Protein kinase C isoforms changes induced by chemical ischemia-reperfusion in rat cerebral cortex slices 133
2-phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrozole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxis 131
Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morpholino Conjugate Antisense Oligonucleotides and Are Ineffective for Phosphorodiamidate Morpholino-Mediated Gene Silencing of DUX4 130
chemotactic formylpeptides activation of protein kinase C and mitogen-activated protein kinases in human neutrophils 129
Study of synthetic peptides derived from PKI55, a PKC modulator, in stimulated human neutrophils. 127
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 125
Chromatin configuration, RNA and protein studies identified novel DNA elements that influence the dystrophin transcription dynamics 123
A 'pure' chemoattractant formylpeptide analogue triggers a specific signalling pathway in human neutrophil chemotaxis 121
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy 121
Nanoparticles to deliver antisense oligonucleotides aimed at exon skipping therapies 117
ncRNAs originating from the dystrophin gene as biomarker for assessing antisense therapy 113
null 113
Specific activation of mitogen-activated protein kinases and protein kinase C isoforms in formylpeptides-induced human neutrophils chemotaxis. 101
Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases 98
null 96
Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice 96
null 94
null 92
null 92
Nanoparticles are effective vehicles for systemic delivery of 2 ' OMePS antisense oligonucleotides in exon skipping-mediated dystrophin restoration 91
null 90
MECP2 mRNA Profile in Brain Tissues from a Rett Syndrome Patient and Three Human Controls: Mutated Allele Preferential Transcription and In Situ RNA Mapping 89
Effects of PKI55 protein, an endogenous protein kinase C modulator, on specific PKC isoforms activity and on human T cells proliferation 89
Synthetic formyl tripeptide chemoattractants: a C-alpha,C-alpha-dialkylated, amphiphilic glycyl residue at position 1 88
Effects of chemical ischemia on cerebral cortex slices: focus on mitogen-activated protein kinase cascade. 88
null 87
New-pyrazolyl-ureas as potent human neutrophil chemotaxis inhibitors 87
Pre-trial antisense screening of myogenic cells from boys with Duchenne muscular dystrophy and genomic and transcriptomic biomarkers discovery for treatment monitoring 86
mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies 84
new pyrazolyl ureas as potent human neutrophil chemotaxis inhibitors 82
null 80
Formylpeptides trigger selective molecular pathways that are required in the physiological functions of human neutrophils. 80
Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils 56
Totale 12.943
Categoria #
all - tutte 54.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 679
Totale 54.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021663 0 0 0 0 0 110 70 112 34 138 111 88
2021/2022840 31 101 58 27 28 26 62 45 33 53 124 252
2022/2023853 79 80 25 112 165 110 48 58 80 15 53 28
2023/2024582 44 45 40 16 27 104 31 52 22 18 13 170
2024/20252.198 47 36 161 115 263 227 130 108 350 258 264 239
2025/20263.526 624 267 496 829 970 340 0 0 0 0 0 0
Totale 12.943